Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 313 of 6351
-
Can a new lens design sharpen vision after macular surgery?
Symptom relief Not yet recruitingPhacoexistence, the first surgical procedure performed in France, naturally raises the question of lens replacement. In recent years, the choice of intraocular lenses has expanded considerably. The term EDOF (Extended Depth of Focus) refers to intraocular lenses offering an exten…
Sponsor: Almaviva Sante • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Can a nerve pain drug calm the bladder?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether adding mirogabalin to educational-behavioral modification program (EBMP) improves symptoms and safety outcomes for adults living with interstitial cystitis/bladder pain syndrome (IC/BPS). The main questions this study aims to a…
Phase 1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new infusion drug shrink Hard-to-Treat tumors?
Disease control Not yet recruitingThis is a first-in-human, multicenter, open-label Phase Ia/Ib study evaluating the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and preliminary antitumor activity of SM2275 in patients with advanced or metastatic solid tumors who have progre…
Phase 1 • Sponsor: Beijing StarMab Biomed Technology Ltd • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for Hard-to-Treat breast cancer: drug combo targets resistant tumors
Disease control Not yet recruitingAlthough treatments for breast cancer have improved, 20-30% of patients with early disease develop metastases (cancer that spreads to other parts of the body). Among the different types of breast cancer, hormone-sensitive cancers that do not overexpress the HER2 protein (HR+/HER2…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a higher dose of digestive enzymes better restore gut health after surgery?
Disease control Not yet recruitingThis study aims to investigate the efficacy and safety of high-dose Oryz-Aspergillus Enzyme And Pancreatin Tablet in treating postoperative pancreatic exocrine insufficiency (PEI), aiming to fill the gap in evidence-based medicine and promote standardized treatment.
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo shows promise for aggressive lymphoma
Disease control Not yet recruitingThis phase II trial studies how well epcoritamab works in combination with the chemotherapy regimen dose adjusted etoposide, prednisone, Oncovin (vincristine), cyclophosphamide, hydroxydaunorubicin-rituximab (DA-EPOCH-R) in treating patients with high risk Burkitt lymphoma. Epcor…
Phase 2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a radiation boost keep early Voice-Box cancer from returning?
Disease control Recruiting nowThere remains no uniform treatment modality for glottic laryngeal carcinoma. Current clinical guidelines broadly recommend surgery or radiotherapy as single modality treatment for early stage glottic laryngeal carcinoma. Glottic carcinoma with anterior commissure invasion is link…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a routine surgical step prevent ureter injuries in hysterectomy?
Disease control Not yet recruitingThis randomized controlled trial will compare routine bilateral ureterolysis with selective ureterolysis during total laparoscopic hysterectomy for benign gynecological conditions. Participants will be allocated to either routine ureter identification and dissection before uterin…
Sponsor: ClinAmygate • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Brain-Wave algorithm may flag newborns needing urgent cooling
Diagnosis Not yet recruitingThis retrospective, multicenter, observational study evaluates how well a decision-support algorithm can tell apart mild forms of hypoxic-ischemic encephalopathy (HIE) from moderate or severe forms in full-term newborns born after a lack of oxygen around birth (perinatal asphyxia…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Sound waves vs. uterine pain: can HIFU calm adenomyosis?
Disease control Not yet recruitingTo assess the efficacy of High-Intensity Focused Ultrasound on adenomyosis
Sponsor: Far Eastern Memorial Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can your own blood help stop leakage? a new trial investigates
Disease control Not yet recruitinghis prospective interventional study will evaluate the effectiveness and safety of peri-urethral injections of platelet-rich plasma for treating stress urinary incontinence in postmenopausal women. Platelet-rich plasma is prepared from each participant's own blood and contains co…
Sponsor: Benha University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Magic mushroom compound tested for cancer pain relief
Symptom relief Not yet recruitingThis phase II trial studies whether psilocybin with psychotherapy is safe and if it works for improving chronic pain in cancer patients who require opioids to manage their pain. Psilocybin is taken from the mushroom Psilocybe mexicana. Psilocybin acts on the brain to cause halluc…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a biomarker test unlock better treatment for Right-Sided colon cancer?
Disease control Not yet recruitingThe aim of this trial is to assess the feasibility of EREG/AREG assessment as a clinical diagnostic standard, used to guide clinical decision making in right-PTL, RAS-wt aCRC. Further to this, the aim is to determine whether EREG/AREG status identifies right-PTL participants who …
Phase 4 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a diabetes drug reverse scarring hair loss?
Disease control Not yet recruitingThe goal of this pilot clinical trial is to learn if tirzepatide can treat active central centrifugal cicatricial alopecia (CCCA), a type of permanent scarring hair loss, in adults. The main questions it aims to answer are: * Does tirzepatide improve the symptoms and signs of ac…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new injection tame lupus when standard care fails?
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and preliminary efficacy of ACG102 administered via intravenous injection in patients with refractory active systemic lupus erythematosus (SLE)
Early phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Mind over bladder: can sleep training curb nighttime urges?
Symptom relief Not yet recruitingThe goal of this clinical trial is to examine and compare the effect of behavioral sleep treatment: BBTI (brief behavioral treatment of insomnia) and brief mindfulness (MI), independently and combined vs control on frequency of nighttime awakenings to void (nocturia) and on night…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a statin nanoparticle save sight in retinitis pigmentosa?
Disease control Not yet recruitingRetinitis pigmentosa (RP) is a rare inherited retinal degenerative disease that causes progressive visual field loss and vision impairment, often leading to blindness. Currently, there are limited treatment options capable of slowing disease progression for the majority of patien…
Phase 1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Electric pulses vs. weights: which better revitalizes cells?
Disease control Not yet recruitingThis study aims to compare the effects of eight weeks of resistance training versus electrical muscle stimulation (EMS) on oxidative stress indicators and cellular health index in overweight and obese women aged 35-45 years. Forty-two participants will be randomly assigned to thr…
Sponsor: Birjand University of Medical Sciences • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A brain stimulation trial aims to rewire the circuit behind depression
Disease control Not yet recruitingThe goal of this clinical trial is to learn how transcranial magnetic stimulation (TMS) affects brain circuits involving the subgenual anterior cingulate cortex (sgACC) in adults with depression. The main questions it aims to answer are: * Can brain responses in the sgACC before…
Early phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Liver cancer trial aims to boost immunotherapy with targeted chemo
Disease control Not yet recruitingStudy Objectives: Atezolizumab (anti-programmed death-ligand 1; anti-PD-L1) combined with bevacizumab (anti-vascular endothelial growth factor; anti-VEGF) or Durvalumab (anti-programmed death-ligand 1; anti-PD-L1) combined with tremelimumab (anti-cytotoxic T-lymphocyte-associated…
Phase 2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC